NIH-funded research R01 grant

Investigating B cells in patients with emphysema-predominant COPD

Official title: B cell-adaptive Immune Profile in Emphysema-predominant COPD

Funded at Baylor College of Medicine · NIH-10906676 · Data updated 2026-11-12

This study is looking at how a type of immune cell called B cells acts in people with emphysema, a form of chronic lung disease, to see how these changes might be linked to lung damage, and it involves analyzing samples from patients to better understand what's happening in their lungs.

More COPD research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 1, 2020
Project endAugust 31, 2025
Funding year2024
Award (this year)$626,411
NIH project number5R01HL149744-06
Project IDNIH-10906676 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with emphysema-predominant COPD, regardless of the severity of their airflow limitation.

Less likely to help

Patients with COPD who do not have emphysema may not benefit from this research.

What this research studies

This research focuses on understanding how B cells, a type of immune cell, behave in patients with emphysema-predominant chronic obstructive pulmonary disease (COPD). The study aims to identify specific changes in the B cell profile and their relationship to lung damage. Researchers will analyze lung tissue and blood samples from COPD patients to assess B cell activity and characteristics, using advanced techniques like immunostaining and next-generation sequencing. By comparing patients with varying degrees of emphysema, the research seeks to uncover the underlying mechanisms that contribute to lung destruction in these individuals.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies targeting B cells to improve outcomes for patients with emphysema-predominant COPD.

How similar studies have gone: Other research has shown promising results in understanding immune responses in COPD, making this approach both relevant and potentially impactful.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Polverino, Francesca — Baylor College of Medicine
  • Study coordinator: Polverino, Francesca

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.